Japan has approved use of a new basal insulin from Novo Nordisk, insulin degludec. It is being promoted by the company as having a duration of action up to 42 hours. The press release is here.
top of page
Search
Recent Posts
See AllThe first “smart” insulin pen has finally hit the market. This is a big moment for diabetes care, as the digital toolbox expands. (I...
The Swedish Obese Subjects study is a fabulous example of how very-useful practical knowledge can come out of a well-conducted cohort...
bottom of page
Comments